TELL ME MORE

ABOUT THIS CLINICAL TRIAL for an INFANT MENINGOCOCCAL VACCINE

This is an Immunogenicity and Safety Study of a Quadrivalent Vaccine Administered Concomitantly with Routine Pediatric Vaccines in Healthy Infants age 42 – 89 days old

Infant Meningococcal Vaccine

Infant Meningococcal Vaccine

Study Location(s): Evansville Indiana

This study evaluates the safety and immunogenicity of a 4-dose series of the quadrivalent Meningococcal Polysaccharide (Serogroups A, C, Y, and W) in healthy infants and toddlers in comparison to MENVEO® when both are administered concomitantly with routine pediatric vaccines.   Click here for more information on Meningococcal vaccines.

There is no cost to participate.  Volunteers receive free vaccines and follow-up care.  No insurance needed.  Time and travel reimburrsement up to $400 may be available.

Watch a 2-minute video about Infant Meningococcal Vaccine

View More Studies

[table id=1 /]

Why are we asking for this information?

Baby’s due date/Birthday helps us ensure the diapers go to their intended recipients, expecting parents and newborns.  By registering for this giveaway you agree to let Qualmedica Reseasrch send information on infant formula and vaccine studies from time to time.  Click here for a complete listing of our privacy policy.

Pin It on Pinterest